A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential.
about
Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous PathologyCurrent efforts and future prospects in the development of live mycobacteria as vaccinesThe Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesisProtein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infectionFbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis.The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells.The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophagesSecretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs.Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesisDisruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice.TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis.Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes.A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.A systems biology approach to study the phagosomal proteome modulated by mycobacterial infections.The ins and outs of Mycobacterium tuberculosis protein export.An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.Label-free proteomics and systems biology analysis of mycobacterial phagosomes in dendritic cells and macrophages.Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2.Characterisation of iunH gene knockout strain from Mycobacterium tuberculosis.Protein dynamics in iron-starved Mycobacterium tuberculosis revealed by turnover and abundance measurement using hybrid-linear ion trap-Fourier transform mass spectrometry.Principal Component Analysis of Proteome Dynamics in Iron-starved Mycobacterium Tuberculosis.The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide.Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells.
P2860
Q26770855-E76C3141-FCCA-46E0-A229-E5854727CF6FQ28087077-107AECEB-DBF0-49BD-A81B-17EF4F909D55Q28486552-DAAB27B9-03B5-40E7-961B-87917C63A259Q28486937-32CA40CC-A042-40BE-ADF5-4466E75A4A2CQ33223435-BBFB232E-8D26-4D41-972E-D64AF56CBE29Q33318121-788795D7-FC28-4DA2-BCBF-B6E5EC1EC188Q34264596-6DB96780-CA6C-49D1-AFB1-829B3E54CE9AQ35035800-FF7C8FD8-9E1D-4C1E-ABDF-3ED23D972729Q35867371-33A4E877-1FC4-446E-9F07-C9AF8E40A5F5Q36038717-4C2260B4-4DCA-40A6-AE57-9FB6C5849370Q36109585-6FA3FF0A-6A6B-4433-B752-D619219A7261Q36277455-ED42A4A3-F51C-41B7-B165-872EAAF3894AQ36929373-4FFD50E2-E8FB-42E3-8486-DEBFC628E4BBQ36973760-392D70C0-4319-4890-B8E4-19CF7CCA750CQ37188632-1BEFC947-FDB9-45A7-9FAE-0F15D8E3E8D4Q37412779-12B99FD1-5366-401C-9BD5-009DFF21EC50Q37970858-F1980DF9-B4C7-405E-A9C4-8AAEEFFB5315Q38041566-4DD27BF9-35A8-4763-B8B7-192D6DA07DF2Q39574791-11226B9A-6E57-4773-A27A-ED807085AF96Q40240877-2879C3D5-E668-4686-86A4-3D69BF26E21AQ40321976-3C83C29D-D2E6-4BE5-8524-9057A42894EDQ42059001-82B813C3-301D-4DDD-8A48-711E3EDB3758Q42257227-B1698D45-2BBD-4488-BEF8-3CF392B1264CQ43043113-3D12C999-26C0-48C1-B52D-44CD507259ECQ44676853-7F8BCFDC-F5D4-4D54-969A-DC407DFB9EEFQ46104296-D485DB0D-3341-4C95-AA4A-79B9CB6CF9F2
P2860
A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A mutant of Mycobacterium tube ...... etains vaccinogenic potential.
@en
A mutant of Mycobacterium tube ...... etains vaccinogenic potential.
@nl
type
label
A mutant of Mycobacterium tube ...... etains vaccinogenic potential.
@en
A mutant of Mycobacterium tube ...... etains vaccinogenic potential.
@nl
prefLabel
A mutant of Mycobacterium tube ...... etains vaccinogenic potential.
@en
A mutant of Mycobacterium tube ...... etains vaccinogenic potential.
@nl
P2093
P2860
P1476
A mutant of Mycobacterium tube ...... etains vaccinogenic potential.
@en
P2093
Audrey Wanger
Chinnaswamy Jagannath
Eliud Sepulveda
Lisa Y Armitige
Robert H Copenhaver
Robert L Hunter
P2860
P304
P356
10.1128/IAI.72.12.7084-7095.2004
P407
P577
2004-12-01T00:00:00Z